Insider · CIK 0001772891
Debra K. Liebert
Files at MIST (Milestone Pharmaceuticals Inc.). First filing Oct 21, 2022, latest Oct 21, 2022.
In brief
Debra K. Liebert files SEC Form 4 as director at MIST (Milestone Pharmaceuticals Inc.). Since Oct 21, 2022, Debra K. Liebert has reported 1 open-market buy worth $74k and 0 open-market sells worth $0, the latest filed on Oct 21, 2022.
A track record needs three past buys with six months of prices behind them; Debra K. Liebert has 0, so none is measured yet.
The newest scored trade: bought $74k of MIST on Oct 20, 2022, filed Oct 21, 2022, scored 54 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MIST: Milestone Pharmaceuticals Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 54Moderate | Milestone Pharmaceuticals Inc. | $74k 14,000 shares | - | +28% from low-45% from high |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 11, 2025 | MIST Milestone Pharmaceuticals Inc. | AGrant or award Common Shares | +16,666 | - | - | 16,793 | Jul 15, 2025 |
| Jul 11, 2025 | MIST Milestone Pharmaceuticals Inc. | AGrant or award Series A Common Warrants (right to buy)derivative | +16,793 | - | - | 16,793 | Jul 15, 2025 |
| Jul 11, 2025 | MIST Milestone Pharmaceuticals Inc. | AGrant or award Series B Common Warrants (right to buy)derivative | +16,793 | - | - | 16,793 | Jul 15, 2025 |
| Oct 20, 2022 | MIST Milestone Pharmaceuticals Inc. | POpen-market purchase Common Sharesindirect: By: The Rodriguez and Liebert Revocable Trust | +10,000 | $5.29 | $53k | 10,000 | Oct 21, 2022 |
| Oct 21, 2022 | MIST Milestone Pharmaceuticals Inc. | POpen-market purchase Common Sharesindirect: By: Trust | +4,000 | $5.26 | $21k | 4,000 | Oct 21, 2022 |
Questions about Debra K. Liebert
Answered from the filings on this page, as of the latest one.
Is Debra K. Liebert buying or selling?
Not in the last 12 months. Debra K. Liebert's latest open-market trade on SEC Form 4 was bought $74k of MIST on Oct 20, 2022.
How did Debra K. Liebert's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Debra K. Liebert has 0.
Where does Debra K. Liebert file Form 4?
Debra K. Liebert has filed Form 4 at MIST (Milestone Pharmaceuticals Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.